Tapewire

Nasdaq · USD

DNLI

Denali Therapeutics Inc.

Export transactions ↓
Tapewire entity
1735
SEC CIK
0001714899
Parsed reports
436

Last 12 months

Inside the activity.

0 purchase rows · 7 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202602
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202601
Sep 202604
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
January 09, 2023 Filed Jan 10, 2023 21:51 UTC
Ho CaroleChief Medical Officer
SaleCommon Stock 1,459 $28.48 $41,552.32
Disclosure

SEC source: 0001714899-23-000017 · wf-form4_167338746261232.xml · nonDerivative · entry 1

Ho Carole · CIK 0001724605 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 177,454

F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan.

F2 · ownership.nature: The shares are held of record by the Rohatgi-Ho Family 2009 Revocable Trust, for which Reporting Person serves as trustee.

Read SEC document
January 06, 2023 Filed Jan 10, 2023 02:43 UTC
Ho CaroleChief Medical Officer
SaleCommon Stock 1,451 $28.67 $41,600.17
Disclosure

SEC source: 0001714899-23-000016 · wf-form4_167331860319501.xml · nonDerivative · entry 2

Ho Carole · CIK 0001724605 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 178,913

F5 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan.

F4 · ownership.nature: The shares are held of record by the Rohatgi-Ho Family 2009 Revocable Trust, for which Reporting Person serves as trustee.

Read SEC document
January 05, 2023 Filed Jan 10, 2023 02:41 UTC
Watts Ryan J.Director · President and CEO
SaleCommon Stock 4,800 $28.44 $136,512.00
Disclosure

SEC source: 0001714899-23-000013 · wf-form4_167331845186326.xml · nonDerivative · entry 1

Watts Ryan J. · CIK 0001724310 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 2,223,664

F1 · kind: Shares sold to satisfy the tax obligations by the reporting person in connection with the settlement of previously vested restricted stock units.

F2 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $28.17 to $28.70 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.

F3 · balance_after: Reflects the issuance of shares to the Watts Family 2015 Trust in connection with the vesting of 15,000 restricted stock units held by the Reporting Person.

F4 · ownership.nature: The shares are held of record by the Watts Family 2015 Trust dated July 7, 2015, for which the Reporting Person serves as trustee.

Read SEC document
January 05, 2023 Filed Jan 10, 2023 02:41 UTC
Schuth Alexander O.COFO and Secretary
SaleCommon Stock 2,636 $28.44 $74,967.84
Disclosure

SEC source: 0001714899-23-000014 · wf-form4_167331850392461.xml · nonDerivative · entry 1

Schuth Alexander O. · CIK 0001724311 · COFO and Secretary

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 497,173

F1 · kind: Shares sold to satisfy the tax obligations by the Reporting Person in connection with the settlement of previously vested restricted stock units.

F2 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $28.17 to $28.68 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.

F3 · balance_after: Reflects the issuance of shares to The Schuth Family Trust U/A DTD 06/05/2017 in connection with the vesting of 7,500 RSUs held by the Reporting Person.

F4 · ownership.nature: The shares are held of record by The Schuth Family Trust U/A DTD 06/05/2017, for which the Reporting Person serves as trustee.

Read SEC document
January 05, 2023 Filed Jan 10, 2023 02:42 UTC SaleCommon Stock 2,970 $28.44 $84,466.80
Disclosure

SEC source: 0001714899-23-000015 · wf-form4_167331855351574.xml · nonDerivative · entry 1

Krognes Steve E. · CIK 0001666236 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 146,498

F1 · kind: Shares sold to satisfy the tax obligations by the reporting person in connection with the settlement of previously vested restricted stock units.

F2 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $28.17 to $28.70 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.

F3 · balance_after: Includes 43,822 restricted stock units.

Read SEC document
January 05, 2023 Filed Jan 10, 2023 02:43 UTC
Ho CaroleChief Medical Officer
SaleCommon Stock 2,636 $28.44 $74,967.84
Disclosure

SEC source: 0001714899-23-000016 · wf-form4_167331860319501.xml · nonDerivative · entry 1

Ho Carole · CIK 0001724605 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 180,364

F1 · kind: Shares sold to satisfy the tax obligations by the reporting person in connection with the settlement of previously vested restricted stock units.

F2 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $28.17 to $28.68 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.

F3 · balance_after: Reflects the issuance of shares to the Rohatgi-Ho Family 2009 Revocable Trust in connection with the vesting of 7,500 RSUs held by the Reporting Person.

F4 · ownership.nature: The shares are held of record by the Rohatgi-Ho Family 2009 Revocable Trust, for which Reporting Person serves as trustee.

Read SEC document
January 04, 2023 Filed Jan 6, 2023 02:08 UTC
Ho CaroleChief Medical Officer
SaleCommon Stock 2,913 $28.69 $83,573.97
Disclosure

SEC source: 0001209191-23-002184 · doc4.xml · nonDerivative · entry 2

Ho Carole · CIK 0001724605 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 175,500

F4 · kind: Shares sold to satisfy the tax obligations by the Reporting Person in connection with the settlement of previously vested RSUs.

F5 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $28.48 to $28.97 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.

F3 · balance_after: Reflects the issuance of shares to the Rohatgi-Ho Family 2009 Revocable Trust in connection with the vesting of 7,750 RSUs held by the Reporting Person.

F6 · ownership.nature: The shares are held of record by the Rohatgi-Ho Family 2009 Revocable Trust, for which Reporting Person serves as trustee.

Read SEC document
January 04, 2023 Filed Jan 6, 2023 02:07 UTC
Watts Ryan J.Director · President and CEO
SaleCommon Stock 5,029 $28.73 $144,483.17
Disclosure

SEC source: 0001209191-23-002179 · doc4.xml · nonDerivative · entry 2

Watts Ryan J. · CIK 0001724310 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 2,213,464

F4 · kind: Shares sold to satisfy the tax obligations by the Reporting Person in connection with the settlement of previously vested RSUs.

F5 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $28.58 to $29.00 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.

F2 · balance_after: Reflects the issuance of shares to the Watts Family 2015 Trust in connection with the vesting of 15,500 RSUs held by the Reporting Person.

F6 · ownership.nature: The shares are held of record by the Watts Family 2015 Trust dated July 7, 2015, for which the Reporting Person serves as trustee.

Read SEC document
January 04, 2023 Filed Jan 6, 2023 02:07 UTC
Schuth Alexander O.COFO and Secretary
SaleCommon Stock 2,912 $28.70 $83,574.40
Disclosure

SEC source: 0001209191-23-002181 · doc4.xml · nonDerivative · entry 2

Schuth Alexander O. · CIK 0001724311 · COFO and Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 149,828

F3 · kind: Shares sold to satisfy the tax obligations by the Reporting Person in connection with the settlement of previously vested RSUs.

F4 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $28.48 to $28.96 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.

F2 · balance_after: Includes 138,192 RSUs.

F5 · balance_after: Reflects the issuance of shares to The Schuth Family Trust U/A DTD 06/05/2017 in connection with the vesting of 7,750 RSUs held by the Reporting Person.

Read SEC document
January 04, 2023 Filed Jan 9, 2023 21:05 UTC Amendment
Schuth Alexander O.COFO and Secretary
SaleCommon Stock 2,912 $28.70 $83,574.40
Disclosure

SEC source: 0001209191-23-002545 · doc4a.xml · nonDerivative · entry 1

Schuth Alexander O. · CIK 0001724311 · COFO and Secretary

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 492,309

F1 · kind: Shares sold to satisfy the tax obligations by the Reporting Person in connection with the settlement of previously vested RSUs.

F2 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $28.48 to $28.96 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.

F3 · balance_after: Reflects the issuance of shares to The Schuth Family Trust U/A DTD 06/05/2017 in connection with the vesting of 7,750 RSUs held by the Reporting Person.

F4 · ownership.nature: The shares are held of record by The Schuth Family Trust U/A DTD 06/05/2017, for which the Reporting Person serves as trustee.

Read SEC document
January 03, 2023 Filed Jan 6, 2023 02:08 UTC
Ho CaroleChief Medical Officer
GrantStock Option (right to buy) · Derivative 123,360 $0.00 Strike: $27.63 $0.00
Disclosure

SEC source: 0001209191-23-002184 · doc4.xml · derivative · entry 4

Ho Carole · CIK 0001724605 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 123,360

Underlying: Common Stock · 123,360 shares

Expires 2033-01-02

F8 · derivative.exercise_date: 25% of the shares subject to the option shall vest on January 3, 2024, and 1/48 of the shares subject to the option shall vest each month thereafter, subject to the Reporting Person remaining a service provider of the Issuer through each such date.

Read SEC document
January 03, 2023 Filed Jan 6, 2023 02:08 UTC
Ho CaroleChief Medical Officer
GrantCommon Stock 41,120 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-002184 · doc4.xml · nonDerivative · entry 1

Ho Carole · CIK 0001724605 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 138,967

F1 · shares: Each share is represented by a Restricted Stock Unit ("RSU") and a contingent right to receive one share of common stock of the Issuer. 25% of the RSUs shall vest on January 3, 2024 (the "Vesting Commencement Date") and an additional 25% of the RSUs shall vest on each annual anniversary of the Vesting Commencement Date thereafter, subject to the Reporting Person remaining a service provider of the Issuer through each such date.

F2 · balance_after: Includes 138,557 RSUs.

F3 · balance_after: Reflects the issuance of shares to the Rohatgi-Ho Family 2009 Revocable Trust in connection with the vesting of 7,750 RSUs held by the Reporting Person.

Read SEC document
January 03, 2023 Filed Jan 6, 2023 02:07 UTC
Watts Ryan J.Director · President and CEO
GrantStock Option (right to buy) · Derivative 246,720 $0.00 Strike: $27.63 $0.00
Disclosure

SEC source: 0001209191-23-002179 · doc4.xml · derivative · entry 3

Watts Ryan J. · CIK 0001724310 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 246,720

Underlying: Common Stock · 246,720 shares

Expires 2033-01-02

F7 · derivative.exercise_date: 25% of the shares subject to the option shall vest on January 3, 2024, and 1/48 of the shares subject to the option shall vest each month thereafter, subject to the Reporting Person remaining a service provider of the Issuer through each such date.

Read SEC document
January 03, 2023 Filed Jan 6, 2023 02:07 UTC
Watts Ryan J.Director · President and CEO
GrantCommon Stock 82,240 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-002179 · doc4.xml · nonDerivative · entry 1

Watts Ryan J. · CIK 0001724310 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 231,934

F1 · shares: Each share is represented by a Restricted Stock Unit ("RSU") and a contingent right to receive one share of common stock of the Issuer. 25% of the RSUs shall vest on January 3, 2024 (the "Vesting Commencement Date") and an additional 25% of the RSUs shall vest on each annual anniversary of the Vesting Commencement Date thereafter, subject to the Reporting Person remaining a service provider of the Issuer through each such date.

F2 · balance_after: Reflects the issuance of shares to the Watts Family 2015 Trust in connection with the vesting of 15,500 RSUs held by the Reporting Person.

F3 · balance_after: Includes 231,934 RSUs.

Read SEC document
January 03, 2023 Filed Jan 6, 2023 02:07 UTC
Schuth Alexander O.COFO and Secretary
GrantStock Option (right to buy) · Derivative 123,360 $0.00 Strike: $27.63 $0.00
Disclosure

SEC source: 0001209191-23-002181 · doc4.xml · derivative · entry 4

Schuth Alexander O. · CIK 0001724311 · COFO and Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 123,360

Underlying: Common Stock · 123,360 shares

Expires 2033-01-02

F7 · derivative.exercise_date: 25% of the shares subject to the option shall vest on January 3, 2024, and 1/48 of the shares subject to the option shall vest each month thereafter, subject to the Reporting Person remaining a service provider of the Issuer through each such date.

Read SEC document
January 03, 2023 Filed Jan 6, 2023 02:07 UTC
Schuth Alexander O.COFO and Secretary
GrantCommon Stock 41,120 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-002181 · doc4.xml · nonDerivative · entry 1

Schuth Alexander O. · CIK 0001724311 · COFO and Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 157,578

F1 · shares: Each share is represented by a Restricted Stock Unit ("RSU") and a contingent right to receive one share of common stock of the Issuer. 25% of the RSUs shall vest on January 3, 2024 (the "Vesting Commencement Date") and an additional 25% of the RSUs shall vest on each annual anniversary of the Vesting Commencement Date thereafter, subject to the Reporting Person remaining a service provider of the Issuer through each such date.

F2 · balance_after: Includes 138,192 RSUs.

Read SEC document
November 23, 2022 Filed Nov 29, 2022 00:30 UTC SaleCommon Stock 20,000 $30.48 $609,600.00
Disclosure

SEC source: 0001714899-22-000148 · wf-form4_166968178535428.xml · nonDerivative · entry 1

Tessier-Lavigne Marc · CIK 0001437435 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,870,356

F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $30.15 to $31.09 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.

F3 · balance_after: Includes 5,986 unvested restricted stock units.

Read SEC document
November 02, 2022 Filed Nov 3, 2022 21:37 UTC SaleCommon Stock 11,252 $30.33 $341,273.16
Disclosure

SEC source: 0001714899-22-000146 · wf-form4_166751143725460.xml · nonDerivative · entry 2

Tessier-Lavigne Marc · CIK 0001437435 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,890,356

F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan.

F4 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $30.00 to $30.90 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.

F3 · balance_after: Includes 5,986 unvested restricted stock units.

Read SEC document
November 01, 2022 Filed Nov 3, 2022 21:37 UTC SaleCommon Stock 8,748 $30.20 $264,189.60
Disclosure

SEC source: 0001714899-22-000146 · wf-form4_166751143725460.xml · nonDerivative · entry 1

Tessier-Lavigne Marc · CIK 0001437435 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,901,608

F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $30.00 to $30.48 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.

F3 · balance_after: Includes 5,986 unvested restricted stock units.

Read SEC document
October 07, 2022 Filed Oct 12, 2022 20:05 UTC
Schuth Alexander O.COFO and Secretary
Exercise / conversionStock Option (right to buy) · Derivative 20,000 $0.00 Strike: $0.68 $0.00
Disclosure

SEC source: 0001714899-22-000135 · wf-form4_166560511822999.xml · derivative · entry 3

Schuth Alexander O. · CIK 0001724311 · COFO and Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 220,078

Underlying: Common Stock · 20,000 shares

Expires 2025-08-20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The vesting of the shares subject to the option is contingent upon the achievement of certain performance metrics. 50% of the shares subject to the option vested on the date the closing price of Issuer's Common Stock equaled or exceeded $40.00 per share on NASDAQ for 90 consecutive trading days, beginning no earlier than June 10, 2018; and 50% of the shares subject to the option vest on the date the closing price of Issuer's Common Stock equals or exceeds $80.00 per share on NASDAQ for 90 consecutive trading days, beginning no earlier than June 10, 2018.

Read SEC document
October 07, 2022 Filed Oct 12, 2022 20:05 UTC
Schuth Alexander O.COFO and Secretary
Exercise / conversionCommon Stock 20,000 $0.68 $13,600.00
Disclosure

SEC source: 0001714899-22-000135 · wf-form4_166560511822999.xml · nonDerivative · entry 1

Schuth Alexander O. · CIK 0001724311 · COFO and Secretary

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 487,471

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Exercised shares were issued to the Schuth Family Trust.

F2 · ownership.nature: The shares are held of record by The Schuth Family Trust U/A DTD 06/05/2017, for which the Reporting Person serves as trustee.

Read SEC document
September 28, 2022 Filed Sep 30, 2022 20:50 UTC SaleCommon Stock 4,423 $31.08 $137,466.84
Disclosure

SEC source: 0001714899-22-000133 · wf-form4_166457103687475.xml · nonDerivative · entry 2

Tessier-Lavigne Marc · CIK 0001437435 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,910,356

F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan.

F4 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $31.00 to $31.31 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.

F3 · balance_after: Includes 5,986 unvested restricted stock units.

Read SEC document
September 28, 2022 Filed Sep 30, 2022 20:50 UTC SaleCommon Stock 15,577 $30.74 $478,836.98
Disclosure

SEC source: 0001714899-22-000133 · wf-form4_166457103687475.xml · nonDerivative · entry 1

Tessier-Lavigne Marc · CIK 0001437435 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,914,779

F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $30.00 to $30.99 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.

F3 · balance_after: Includes 5,986 unvested restricted stock units.

Read SEC document
August 23, 2022 Filed Aug 25, 2022 22:10 UTC
Ho CaroleChief Medical Officer
SaleCommon Stock 2,424 $31.98 $77,519.52
Disclosure

SEC source: 0001714899-22-000130 · wf-form4_166146541259069.xml · nonDerivative · entry 1

Ho Carole · CIK 0001724605 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 170,663

F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan.

F2 · ownership.nature: The shares are held of record by the Rohatgi-Ho Family 2009 Revocable Trust, for which Reporting Person serves as trustee.

Read SEC document
August 23, 2022 Filed Aug 25, 2022 22:11 UTC SaleCommon Stock 100 $32.43 $3,243.00
Disclosure

SEC source: 0001714899-22-000131 · wf-form4_166146545134466.xml · nonDerivative · entry 2

Tessier-Lavigne Marc · CIK 0001437435 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,930,356

F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan.

F3 · balance_after: Includes 5,986 unvested restricted stock units.

Read SEC document
August 23, 2022 Filed Aug 25, 2022 22:11 UTC SaleCommon Stock 19,900 $31.61 $629,039.00
Disclosure

SEC source: 0001714899-22-000131 · wf-form4_166146545134466.xml · nonDerivative · entry 1

Tessier-Lavigne Marc · CIK 0001437435 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,930,456

F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $31.33 to $32.31 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.

F3 · balance_after: Includes 5,986 unvested restricted stock units.

Read SEC document
August 19, 2022 Filed Aug 23, 2022 20:48 UTC
Watts Ryan J.Director · President and CEO
SaleCommon Stock 2,404 $33.22 $79,860.88
Disclosure

SEC source: 0001714899-22-000129 · wf-form4_166128769265555.xml · nonDerivative · entry 1

Watts Ryan J. · CIK 0001724310 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 2,202,993

F1 · kind: Shares sold to satisfy the tax obligations by the reporting person in connection with the settlement of previously vested restricted stock units.

F2 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $33.11 to $33.37 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.

F3 · balance_after: Reflects the issuance of shares to the Watts Family 2015 Trust in connection with the vesting of 5,000 restricted stock units held by the Reporting Person.

F4 · ownership.nature: The shares are held of record by the Watts Family 2015 Trust dated July 7, 2015, for which the Reporting Person serves as trustee.

Read SEC document
August 19, 2022 Filed Aug 23, 2022 20:46 UTC
Schuth Alexander O.COFO and Secretary
SaleCommon Stock 2,576 $33.22 $85,574.72
Disclosure

SEC source: 0001714899-22-000127 · wf-form4_166128759380161.xml · nonDerivative · entry 1

Schuth Alexander O. · CIK 0001724311 · COFO and Secretary

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 467,471

F1 · kind: Shares sold to satisfy the tax obligations by the reporting person in connection with the settlement of previously vested restricted stock units.

F2 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $33.11 to $33.38 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.

F3 · balance_after: Reflects the issuance of shares to the Schuth Family 2017 Trust in connection with the vesting of 5,000 restricted stock units held by the Reporting Person.

F4 · ownership.nature: The shares are held of record by The Schuth Family Trust U/A DTD 06/05/2017, for which the Reporting Person serves as trustee.

Read SEC document
August 19, 2022 Filed Aug 23, 2022 20:47 UTC SaleCommon Stock 2,253 $33.22 $74,844.66
Disclosure

SEC source: 0001714899-22-000128 · wf-form4_166128765076444.xml · nonDerivative · entry 1

Krognes Steve E. · CIK 0001666236 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 149,468

F1 · kind: Shares sold to satisfy the tax obligations by the reporting person in connection with the settlement of previously vested restricted stock units.

F2 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $33.11 to $33.37 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.

F3 · balance_after: Includes 51,322 restricted stock units.

Read SEC document
August 19, 2022 Filed Aug 23, 2022 20:45 UTC
Ho CaroleChief Medical Officer
SaleCommon Stock 2,576 $33.22 $85,574.72
Disclosure

SEC source: 0001714899-22-000126 · wf-form4_166128752453768.xml · nonDerivative · entry 1

Ho Carole · CIK 0001724605 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 173,087

F1 · kind: Shares sold to satisfy the tax obligations by the reporting person in connection with the settlement of previously vested restricted stock units.

F2 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $33.11 to $33.39 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.

F3 · balance_after: Reflects the issuance of shares to the Rohatgi-Ho Family 2009 Revocable Trust in connection with the vesting of 5,000 restricted stock units held by the Reporting Person.

F4 · ownership.nature: The shares are held of record by the Rohatgi-Ho Family 2009 Revocable Trust, for which Reporting Person serves as trustee.

Read SEC document
August 09, 2022 Filed Aug 11, 2022 23:21 UTC
Schuth Alexander O.COFO and Secretary
GrantCommon Stock 22,500 $0.00 $0.00
Disclosure

SEC source: 0001714899-22-000124 · wf-form4_166026004225336.xml · nonDerivative · entry 1

Schuth Alexander O. · CIK 0001724311 · COFO and Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 121,458

F1 · shares: Each share is represented by a Restricted Stock Unit ("RSU") and a contingent right to receive one share of common stock of the Issuer. 25% of the RSUs shall vest on August 9, 2023 (the"Vesting Commencement Date") and an additional 25% of the RSUs shall vest on each annual anniversary of the Vesting Commencement Date thereafter, subject to the Reporting Person remaining a serviceprovider of the Issuer through each such date.

F2 · balance_after: Includes 109,822 restricted stock units.

F3 · balance_after: Includes 540 shares acquired under the ESPP Purchase on May 31, 2022.

Read SEC document
August 09, 2022 Filed Aug 11, 2022 23:22 UTC
Ho CaroleChief Medical Officer
GrantCommon Stock 22,500 $0.00 $0.00
Disclosure

SEC source: 0001714899-22-000125 · wf-form4_166026015800698.xml · nonDerivative · entry 1

Ho Carole · CIK 0001724605 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 110,597

F1 · shares: Each share is represented by a Restricted Stock Unit ("RSU") and a contingent right to receive one share of common stock of the Issuer. 25% of the RSUs shall vest on August 9, 2023 (the "Vesting Commencement Date") and an additional 25% of the RSUs shall vest on each annual anniversary of the Vesting Commencement Date thereafter, subject to the Reporting Person remaining a service provider ofthe Issuer through each such date.

F2 · balance_after: Includes 110,187 restricted stock units.

Read SEC document
July 25, 2022 Filed Jul 27, 2022 22:49 UTC SaleCommon Stock 200 $36.15 $7,230.00
Disclosure

SEC source: 0001714899-22-000109 · wf-form4_165896213456047.xml · nonDerivative · entry 2

Tessier-Lavigne Marc · CIK 0001437435 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,950,356

F3 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $36.03 to $36.27 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.

F2 · balance_after: Includes 5,986 unvested restricted stock units.

Read SEC document
July 25, 2022 Filed Jul 27, 2022 22:49 UTC SaleCommon Stock 19,800 $35.60 $704,880.00
Disclosure

SEC source: 0001714899-22-000109 · wf-form4_165896213456047.xml · nonDerivative · entry 1

Tessier-Lavigne Marc · CIK 0001437435 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,950,556

F1 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $35.02 to $36.01 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.

F2 · balance_after: Includes 5,986 unvested restricted stock units.

Read SEC document
July 19, 2022 Filed Jul 21, 2022 23:36 UTC Exercise / conversionStock Option (right to buy) · Derivative 62,500 $0.00 Strike: $0.68 $0.00
Disclosure

SEC source: 0001714899-22-000107 · wf-form4_165844658516817.xml · derivative · entry 3

Krognes Steve E. · CIK 0001666236 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 62,500 shares

Expires 2022-08-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: 25% of the shares subject to the option vested on March 8, 2018 and an additional 1/48 of the shares vested monthly thereafter.

Read SEC document
July 19, 2022 Filed Jul 21, 2022 23:36 UTC Exercise / conversionCommon Stock 62,500 $0.68 $42,500.00
Disclosure

SEC source: 0001714899-22-000107 · wf-form4_165844658516817.xml · nonDerivative · entry 1

Krognes Steve E. · CIK 0001666236 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 151,721

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 56,322 restricted stock units.

Read SEC document
June 24, 2022 Filed Jun 28, 2022 00:54 UTC Disposition to issuerCommon Stock 6,766 $31.08 $210,260.89
Disclosure

SEC source: 0001628280-22-018113 · wf-form4_165637764875845.xml · nonDerivative · entry 3

Tessier-Lavigne Marc · CIK 0001437435 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,970,356

F4 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $31.00 to $31.19 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.

F2 · balance_after: Includes 5,986 unvested restricted stock units.

Read SEC document
June 24, 2022 Filed Jun 28, 2022 00:54 UTC Disposition to issuerCommon Stock 39,984 $30.53 $1,220,707.52
Disclosure

SEC source: 0001628280-22-018113 · wf-form4_165637764875845.xml · nonDerivative · entry 2

Tessier-Lavigne Marc · CIK 0001437435 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,977,122

F3 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $30.00 to $30.99 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.

F2 · balance_after: Includes 5,986 unvested restricted stock units.

Read SEC document
June 23, 2022 Filed Jun 28, 2022 00:54 UTC Disposition to issuerCommon Stock 13,250 $31.10 $412,076.33
Disclosure

SEC source: 0001628280-22-018113 · wf-form4_165637764875845.xml · nonDerivative · entry 1

Tessier-Lavigne Marc · CIK 0001437435 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,017,106

F1 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $30.00 to $30.19 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.

F2 · balance_after: Includes 5,986 unvested restricted stock units.

Read SEC document
June 02, 2022 Filed Jun 7, 2022 00:09 UTC GrantStock Option (right to buy) · Derivative 17,959 $0.00 Strike: $24.27 $0.00
Disclosure

SEC source: 0001714899-22-000098 · wf-form4_165456058126311.xml · derivative · entry 4

Schenkein David P · CIK 0001578200 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,959

Underlying: Common Stock · 17,959 shares

Expires 2032-06-02

F5 · derivative.exercise_date: 100% of the shares subject to the option shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date.

Read SEC document
June 02, 2022 Filed Jun 7, 2022 00:09 UTC GrantCommon Stock 5,986 $0.00 $0.00
Disclosure

SEC source: 0001714899-22-000098 · wf-form4_165456058126311.xml · nonDerivative · entry 1

Schenkein David P · CIK 0001578200 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,313

F1 · shares: Each share is represented by a Restricted Stock Unit ("RSU") and a contingent right to receive one share of common stock of the Issuer. 100% of the RSUs shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date.

F2 · balance_after: Includes 5,986 unvested restricted stock units.

Read SEC document
June 02, 2022 Filed Jun 7, 2022 00:09 UTC GrantStock Option (right to buy) · Derivative 17,959 $0.00 Strike: $24.27 $0.00
Disclosure

SEC source: 0001714899-22-000097 · wf-form4_165456056392230.xml · derivative · entry 2

Klein Peter S · CIK 0001478007 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,959

Underlying: Common Stock · 17,959 shares

Expires 2032-06-02

F3 · derivative.exercise_date: 100% of the shares subject to the option shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date.

Read SEC document
June 02, 2022 Filed Jun 7, 2022 00:09 UTC GrantCommon Stock 5,986 $0.00 $0.00
Disclosure

SEC source: 0001714899-22-000097 · wf-form4_165456056392230.xml · nonDerivative · entry 1

Klein Peter S · CIK 0001478007 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,313

F1 · shares: Each share is represented by a Restricted Stock Unit ("RSU") and a contingent right to receive one share of common stock of the Issuer. 100% of the RSUs shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date.

F2 · balance_after: Includes 5,986 unvested restricted stock units.

Read SEC document
June 02, 2022 Filed Jun 7, 2022 00:09 UTC GrantStock Option (right to buy) · Derivative 17,959 $0.00 Strike: $24.27 $0.00
Disclosure

SEC source: 0001714899-22-000096 · wf-form4_165456054624289.xml · derivative · entry 5

Tessier-Lavigne Marc · CIK 0001437435 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,959

Underlying: Common Stock · 17,959 shares

Expires 2032-06-02

F3 · derivative.exercise_date: 100% of the shares subject to the option shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date.

Read SEC document
June 02, 2022 Filed Jun 7, 2022 00:09 UTC GrantCommon Stock 5,986 $0.00 $0.00
Disclosure

SEC source: 0001714899-22-000096 · wf-form4_165456054624289.xml · nonDerivative · entry 1

Tessier-Lavigne Marc · CIK 0001437435 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,030,356

F1 · shares: Each share is represented by a Restricted Stock Unit ("RSU") and a contingent right to receive one share of common stock of the Issuer. 100% of the RSUs shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date.

F2 · balance_after: Includes 5,986 unvested restricted stock units.

Read SEC document
June 02, 2022 Filed Jun 7, 2022 00:09 UTC GrantStock Option (right to buy) · Derivative 17,959 $0.00 Strike: $24.27 $0.00
Disclosure

SEC source: 0001714899-22-000095 · wf-form4_165456052861515.xml · derivative · entry 2

Cole Douglas G. · CIK 0001486373 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,959

Underlying: Common Stock · 17,959 shares

Expires 2032-06-02

F4 · derivative.exercise_date: 100% of the shares subject to the option shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date.

Read SEC document
June 02, 2022 Filed Jun 7, 2022 00:09 UTC GrantCommon Stock 5,986 $0.00 $0.00
Disclosure

SEC source: 0001714899-22-000095 · wf-form4_165456052861515.xml · nonDerivative · entry 1

Cole Douglas G. · CIK 0001486373 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,348

F1 · shares: Each share is represented by a Restricted Stock Unit ("RSU") and a contingent right to receive one share of common stock of the Issuer. 100% of the RSUs shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date.

F2 · balance_after: Includes 11,035 shares received in prior distributions-in-kind made in accordance with the exemptions afforded by Rule 16a-13 and Rule 16a-9 of the Securities Exchange Act of 1934, as amended.

F3 · balance_after: Includes 5,986 unvested restricted stock units.

Read SEC document
June 02, 2022 Filed Jun 7, 2022 00:08 UTC
SATO VICKI LDirector
GrantStock Option (right to buy) · Derivative 17,959 $0.00 Strike: $24.27 $0.00
Disclosure

SEC source: 0001714899-22-000094 · wf-form4_165456050784142.xml · derivative · entry 2

SATO VICKI L · CIK 0001197020 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,959

Underlying: Common Stock · 17,959 shares

Expires 2032-06-02

F3 · derivative.exercise_date: 100% of the shares subject to the option shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date.

Read SEC document
June 02, 2022 Filed Jun 7, 2022 00:08 UTC
SATO VICKI LDirector
GrantCommon Stock 5,986 $0.00 $0.00
Disclosure

SEC source: 0001714899-22-000094 · wf-form4_165456050784142.xml · nonDerivative · entry 1

SATO VICKI L · CIK 0001197020 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 142,149

F1 · shares: Each share is represented by a Restricted Stock Unit ("RSU") and a contingent right to receive one share of common stock of the Issuer. 100% of the RSUs shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date.

F2 · balance_after: Includes 5,986 unvested restricted stock units.

Read SEC document
June 02, 2022 Filed Jun 7, 2022 00:08 UTC GrantStock Option (right to buy) · Derivative 17,959 $0.00 Strike: $24.27 $0.00
Disclosure

SEC source: 0001714899-22-000093 · wf-form4_165456048293686.xml · derivative · entry 2

Cook Jennifer E. · CIK 0001754371 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,959

Underlying: Common Stock · 17,959 shares

Expires 2032-06-02

F3 · derivative.exercise_date: 100% of the shares subject to the option shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.